Pre-hospital thrombolysis in ST-segment elevation myocardial infarction: a regional Australian experience
Authors: Arshad A Khan, Peter J Fletcher and Andrew J Boyle
Published online: 1 May 2017
We thank French and colleagues for their letter on our article.1 As mentioned, the first medical contact (FMC) to device time in the primary percutaneous coronary intervention (PCI) arm of our registry1 was significantly longer than the guideline-recommended time of 90 minutes.2 Patients who had any contraindication to thrombolysis underwent primary PCI, irrespective of the travel time from FMC to the cardiac catheterisation laboratory (CCL). Therefore, there will always be patients with longer travel times if they are ineligible for pre-hospital thrombolysis, which will inevitably prolong the average transport time. Moreover, in our protocol, patients are transferred for primary PCI if the estimated FMC-to-CCL travel time is < 60 minutes — these travel times are estimated by the paramedics. At times, factors such as weather conditions or traffic congestion, and clinical reasons, including resuscitation from cardiac arrest and treatment of arrhythmias, may interfere with the transport and result in prolonged travel time. We agree that pre-hospital thrombolysis is a well established alternative for patients with long delays to primary PCI and is supported both by real world and randomised data.3-5 The decision whether to administer pre-hospital thrombolysis or transfer for primary PCI in patients with moderate delays to the CCL is a difficult one, and will be studied for older patients in the upcoming Strategic Reperfusion in Elderly Patients Early After Myocardial Infarction (STREAM-2) trial (http://clinicaltrials.gov/ct2/show/NCT02777580). We agree with French and colleagues that more patients should be considered for pre-hospital thrombolysis if long delays are expected.
Competing interests
References
- Khan AA, Williams T, Savage L, et al. Pre-hospital thrombolysis in ST-segment elevation myocardial infarction: a regional Australian experience. Med J Aust 2016; 205: 121-125.
- Chew DP, Scott IA, Cullen L, et al. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Med J Aust 2016; 205: 128-133.
- Henry TD, Armstrong PW. The choice is reperfusion therapy: but which one? JACC Cardiovasc Interv 2016; 9: 2021-2023.
- Danchin N, Puymirat E, Steg PG, et al. Five-year survival in patients with ST-segment elevation myocardial infarction according to modalities of reperfusion therapy: the French registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) 2005 cohort. Circulation 2014; 129: 1629-1636.
- Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013; 368: 1379-1387.
Estimating Eligibility for GLP-1 Receptor Agonists for Chronic Weight Management and Cardiovascular Disease in Australia: Cross-Sectional Analysis of National Health Survey Data
Jasmin Castrillon, Chris Schilling, Sharmala Thuraisingam, Michael W. Hii, Priya Sumithran, Peter F. Choong, Michelle M. Dowsey, Cade Shadbolt
Seven Vessel Spontaneous Coronary Artery Dissection and Concurrent Transient Global Amnesia After an Emotional Trigger
Michael J. Stewart, Tom R. Sutherland
Seven Vessel Spontaneous Coronary Artery Dissection and Concurrent Transient Global Amnesia After an Emotional Trigger
Virginia Barbour
Designing Housing to Reduce Overcrowding-Related Harms: Rheumatic Heart Disease as the Canary in the Coal Mine
Simon Quilty, Veronica Matthews, Angus Baumann, James Marangou, Bo Remenyi, Gavin Wheaton, Serena Morton Nabanunga, Norman Frank Jupurrurla, Simon Robinson, Steve Mintern, Cary Duffield, Joshua R. Francis, Paul C. Memmott
Diagnosis and Management of Patent Foramen Ovale for Stroke Prevention: An Australian and New Zealand Consensus Statement Developed by a Modified Nominal Group Approach
Brian R. Chambers, Lauren M. Sanders, Amanda Gilligan, Carlos Garcia-Esperon, Jan Ho, John Fink, Matias Yudi, Matthew Lee-Archer, Vimal Stanislaus, Andrew A. Wong